Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-20,200
Closed -$722K 1242
2017
Q3
$722K Buy
+20,200
New +$660K 0.01% 609
2017
Q1
Sell
-11,600
Closed -$434K 1307
2016
Q4
$434K Sell
11,600
-4,400
-28% -$160K 0.01% 769
2016
Q3
$588K Buy
16,000
+6,000
+60% +$202K 0.01% 583
2016
Q2
$336K Buy
10,000
+2,000
+25% +$64.2K 0.01% 708
2016
Q1
$249K Sell
8,000
-22,900
-74% -$700K 0.01% 693
2015
Q4
$1.03M Buy
30,900
+15,100
+96% +$561K 0.03% 452
2015
Q3
$595K Buy
+15,800
New +$646K 0.02% 664
2015
Q1
Sell
-8,000
Closed -$524K 1301
2014
Q4
$524K Sell
8,000
-1,800
-18% -$125K 0.01% 903
2014
Q3
$746K Sell
9,800
-48,300
-83% -$3.99M 0.01% 827
2014
Q2
$4.79M Sell
58,100
-29,511
-34% -$2.2M 0.08% 188
2014
Q1
$6.15M Sell
87,611
-133,524
-60% -$9.16M 0.12% 147
2013
Q4
$15.9M Buy
+221,135
New +$16.1M 0.22% 66

Other funds holding NOV

Integral Derivatives's NOV Position: Q2 2015 in Review

Integral Derivatives sold out of NOV (NOV) in Q2 2015, closing a stake of 13,816 shares — an estimated $710K sold.

Integral Derivatives first reported a position in NOV in Q1 2014 and held it in 4 quarters. The position peaked at $4.11M in Q3 2014. 783 funds tracked by Wall St. Rank hold NOV as of Q2 2015.

  • Integral Derivatives reported no remaining NOV position as of Q2 2015 after selling out during the quarter.
  • Integral Derivatives sold 13,816 NOV shares in Q2 2015, an estimated $710K.
  • Integral Derivatives first reported a position in NOV in Q1 2014 and held it in 4 quarters.
  • Integral Derivatives's NOV position peaked at $4.11M in Q3 2014.
  • 783 funds tracked by Wall St. Rank held NOV as of Q2 2015.

Based on Integral Derivatives's 13F filing for Q2 2015, filed 15 Jul 2015.